Catalyst Pharmaceuticals (CPRX) Net Cash Flow Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 89.97% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -13.44% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 33.37% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -29.82% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 32.17% |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | 32.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.21% |
| Dec 31, 2025 | -23.06% |
| Sep 30, 2025 | -6.34% |
| Jun 30, 2025 | 45.96% |
| Mar 31, 2025 | 108.85% |
| Dec 31, 2024 | 65.45% |
| Sep 30, 2024 | 50.52% |
| Jun 30, 2024 | 101.60% |
| Mar 31, 2024 | 294.49% |
| Dec 31, 2023 | 8.27% |
| Sep 30, 2023 | -211.23% |
| Jun 30, 2023 | 31.93% |
| Mar 31, 2023 | -142.54% |
| Dec 31, 2022 | -1.67% |
| Sep 30, 2022 | 27.93% |
| Jun 30, 2022 | 74.90% |
| Mar 31, 2022 | 40.04% |
| Dec 31, 2021 | 40.86% |
| Sep 30, 2021 | 199.36% |
| Jun 30, 2021 | 41.29% |
| Mar 31, 2021 | 57.50% |
| Dec 31, 2020 | -36.03% |
| Sep 30, 2020 | 53.79% |
| Jun 30, 2020 | 83.24% |
| Mar 31, 2020 | 72.45% |
| Dec 31, 2019 | 140.38% |
| Sep 30, 2019 | 180.15% |
| Jun 30, 2019 | 47.90% |
| Mar 31, 2019 | 34.26% |
| Dec 31, 2018 | 49.12% |
| Sep 30, 2018 | 29.32% |
| Jun 30, 2018 | -33.29% |
| Mar 31, 2018 | -46.99% |
| Dec 31, 2017 | 192.99% |
| Sep 30, 2017 | 29.22% |
| Jun 30, 2017 | -30.71% |
| Mar 31, 2017 | -50.68% |
| Dec 31, 2016 | 29.63% |
| Sep 30, 2016 | -27.84% |
| Jun 30, 2016 | -165.69% |
| Mar 31, 2016 | -98.86% |
| Dec 31, 2015 | 24.67% |
| Sep 30, 2015 | -44.27% |
| Jun 30, 2015 | -52.96% |
| Mar 31, 2015 | 198.78% |
| Dec 31, 2014 | -36.78% |
| Sep 30, 2014 | -41.28% |
| Jun 30, 2014 | 124.95% |
| Mar 31, 2014 | -41.25% |
| Dec 31, 2013 | -140.86% |
| Sep 30, 2013 | 156.04% |